Drawing for UCM

USPTO serial 79255216

UCM

Reviewed by CopyMark Law Group

Reg. 5899779Status 706Registered
Filing date
Status date
Registration date
Nov 5, 2019
Examiner
MACIOL II, EUGENE VALENTINE-JO
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with UCM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roberto Ledesma

Roberto Ledesma Law Office of Roberto LedesmaPO Box 230692New York, NY 10023United States

Goods and services

ClassDescriptionStatusFirst use
001Preservatives for pharmaceutical preparations; preservatives for use in the pharmaceutical industryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 3, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jul 3, 202571AGREGISTERED-SEC.71 ACCEPTED—
Jul 2, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 2, 2025ES71TEAS SECTION 71 RECEIVED—
Mar 13, 2025CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 5, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 30, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 13, 2020FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 27, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 27, 2020FIMPFINAL DISPOSITION PROCESSED—
Feb 5, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 5, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 23, 2019GPNXNOTIFICATION PROCESSED BY IB—
Aug 20, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 20, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 7, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 7, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 31, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 12, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 21, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 21, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 17, 2019ALIEASSIGNED TO LIE—
Jun 12, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2019RFNTREFUSAL PROCESSED BY IB—
May 23, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 23, 2019RFRRREFUSAL PROCESSED BY MPU—
Apr 30, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 29, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2019DOCKASSIGNED TO EXAMINER—
Apr 5, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 1, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 28, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance